They found that increased levels of endogenous growth hormone and IGF-1 do not alter the susceptibility to DSS-induced colitis but enhance survival, reduce local inflammation, and accelerate mucosal repair in this model of experimental colitis [49]. The gene discussed is GH1; the disease is colitis.